In the future, we would like to enlarge the sample size and complete the clinical symptoms, such as the severity of disease, stage of the disease to evaluate the association between CYP2R1 SNPs and the clinical symptoms of CHD. This evidence concerns the gene CYP2R1 and coronary artery disorder.